US EditionPCCA Appoints Gus Bassani, PharmD, as CEO
- PCCA announced Gus Bassani, PharmD, will become CEO of its U.S. Business unit on April 1, 2025, highlighting his extensive leadership experience as a company veteran.
- Bassani has been with PCCA since 2002 and previously served as chief scientific officer, overseeing research and development.
- Bassani emphasized that the safety and care of patients will remain central to PCCA's mission as they advance personalized medicine.
- Under Bassani's leadership, PCCA will focus on pioneering innovations and enhancing support for over 3,000 pharmacies.
Insights by Ground AI
Does this summary seem wrong?
24 Articles
24 Articles
All
Left
Center
13
Right
Cherokee Phoenix+23 Reposted by 23 other sources
PCCA Appoints Gus Bassani, PharmD, as CEO
HOUSTON, March 20, 2025 /PRNewswire/ -- PCCA, a leading FDA-registered supplier of active pharmaceutical ingredients, excipients and consulting for the compounding industry, today announced Gus Bassani, PharmD, will become chief executive officer of its U.S. business unit on April 1,…
Coverage Details
Total News Sources24
Leaning Left0Leaning Right0Center13Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
